An up-to-date overview of therapeutic agents for the treatment of COVID-19 disease
T Mulaw Belete - Clinical pharmacology: advances and …, 2020 - Taylor & Francis
Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has a great potential to
overwhelm the world healthcare systems that may lead to high morbidity and mortality. It …
overwhelm the world healthcare systems that may lead to high morbidity and mortality. It …
Emerging therapeutic approaches to combat COVID-19: present status and future perspectives
K Vivekanandhan, P Shanmugam… - Frontiers in Molecular …, 2021 - frontiersin.org
Coronavirus disease (COVID-19) has emerged as a fast-paced epidemic in late 2019 which
is disrupting life-saving immunization services. SARS-CoV-2 is a highly transmissible virus …
is disrupting life-saving immunization services. SARS-CoV-2 is a highly transmissible virus …
COVID-19 associated complications and potential therapeutic targets
JD Monpara, SJ Sodha, PK Gupta - European Journal of Pharmacology, 2020 - Elsevier
The global pandemic COVID-19, caused by novel coronavirus SARS-CoV-2, has emerged
as severe public health issue crippling world health care systems. Substantial knowledge …
as severe public health issue crippling world health care systems. Substantial knowledge …
Urgent needs to accelerate the race for COVID-19 therapeutics
On December 8, 2020, a 91-year-old woman made history as the first person to receive the
COVID-19 vaccine in the United Kingdom. Worldwide vaccination coverage will take time …
COVID-19 vaccine in the United Kingdom. Worldwide vaccination coverage will take time …
In vitro data of current therapies for SARS-CoV-2
IA Anastasiou, I Eleftheriadou… - Current Medicinal …, 2020 - ingentaconnect.com
Background: In December 2019, a new coronavirus, named Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), emerged from China, causing pneumonia …
Syndrome Coronavirus 2 (SARS-CoV-2), emerged from China, causing pneumonia …
SARS-CoV-2: repurposed drugs and novel therapeutic approaches—insights into chemical structure—biological activity and toxicological screening
CA Dehelean, V Lazureanu, D Coricovac… - Journal of clinical …, 2020 - mdpi.com
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic represents the
primary public health concern nowadays, and great efforts are made worldwide for efficient …
primary public health concern nowadays, and great efforts are made worldwide for efficient …
Treatment for COVID-19: An overview
Abstract Coronavirus disease 2019 (COVID-19) is an infectious disease caused by
coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a …
coronavirus-2 (SARS-CoV-2) that causes a severe acute respiratory syndrome, a …
A global picture: therapeutic perspectives for COVID-19
VP Chavda, C Kapadia, S Soni, R Prajapati… - …, 2022 - Taylor & Francis
The COVID-19 pandemic is a lethal virus outbreak by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …
coronavirus-2 (SARS-CoV-2), which has severely affected human lives and the global …
Therapeutic options against the new coronavirus: updated clinical and laboratory evidences
ACL Fernandes, AJM Vale, FP Guzen… - Frontiers in …, 2020 - frontiersin.org
The pandemic caused by the new coronavirus (SARS-Cov-2) has encouraged numerous in
vitro studies and clinical trials around the world, with research groups testing existing drugs …
vitro studies and clinical trials around the world, with research groups testing existing drugs …
Therapeutic Development and Drugs for the Treatment of COVID-19
VK Maurya, S Kumar, MLB Bhatt, SK Saxena - Coronavirus Disease 2019 …, 2020 - Springer
Abstract SARS-CoV-2/novel coronavirus (2019-nCoV) is a new strain that has recently been
confirmed in Wuhan City, Hubei Province of China, and spreads to more than 165 countries …
confirmed in Wuhan City, Hubei Province of China, and spreads to more than 165 countries …